GC
GILD icon

GMT Capital’s Gilead Sciences GILD Stock Holding History

GMT Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-143,660
Closed -$11.1M – 81
2018
Q3 		$11.1M Sell
143,660
-177,540
-55% -$13.4M 0.29% 62
2018
Q2 		$22.8M Sell
321,200
-236,200
-42% -$16.7M 0.54% 51
2018
Q1 		$42M Hold
557,400
– – 1% 30
2017
Q4 		$39.9M Sell
557,400
-21,400
-4% -$1.63M 0.81% 37
2017
Q3 		$46.9M Buy
578,800
+77,700
+16% +$5.94M 0.94% 35
2017
Q2 		$34.7M Buy
501,100
+57,500
+13% +$3.83M 0.74% 47
2017
Q1 		$30.1M Buy
443,600
+27,900
+7% +$1.96M 0.64% 51
2016
Q4 		$29.8M Buy
415,700
+225,900
+119% +$16.8M 0.62% 52
2016
Q3 		$15M Buy
+189,800
New +$15.4M 0.31% 73

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GMT Capital's GILD Position: Q4 2018 in Review

GMT Capital sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 143,660 shares — an estimated $11.1M sold.

GMT Capital first reported a position in GILD in Q3 2016 and held it in 9 quarters. The position peaked at $46.9M in Q3 2017. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • GMT Capital reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • GMT Capital sold 143,660 Gilead Sciences shares in Q4 2018, an estimated $11.1M.
  • GMT Capital first reported a position in Gilead Sciences in Q3 2016 and held it in 9 quarters.
  • GMT Capital's Gilead Sciences position peaked at $46.9M in Q3 2017.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on GMT Capital's 13F filing for Q4 2018, filed 13 Feb 2019.